OncoDNA
PrivateLast Round
Grant
Jan 17, 2024
Total Funding Raised
$35.77M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OncoDNA is a biotechnology company that provides genomic and theranostic testing services and software to aid oncologists in making personalized treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoDNA Comparables
Compare OncoDNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strata Oncology | 79% | |
| Lucence | 78% | |
| Hedera Dx | 78% |
OncoDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2024 | ||||
| Series C | Jul 3, 2023 | ||||
| Series B | Feb 14, 2020 | ||||
| Series A | Sep 2, 2016 |
Key People
Founding team and executive leadership
OncoDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B, Series C |
| Ackermans & van Haaren | Series B, Series C, Series A |
| Verve Ventures | Series B |
| Inventures | Series A, Series B |
| Société Régionale d'Investissement de Wallonie | Series A, Series B |
| Wallonie Entreprendre | Series C |
| Vesalius Biocapital Partners | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 101% MoM, reaching 4.2K.
- Mar 1, 2026
Upcoming launch of 'fragmentomics' liquid biopsy assay in March 2026.
OncoDNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoDNA's valuation, stock price, and market status.
Is OncoDNA a public or private company?
OncoDNA is a private company.
What is the current stock price of OncoDNA?
OncoDNA is a private company with no public stock price. No recent secondary market data is available.
How much is OncoDNA worth (valuation)?
Valuation information for OncoDNA is not publicly available.
Can I buy OncoDNA stock?
OncoDNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OncoDNA's last funding round?
OncoDNA's most recent funding round was Series C on July 5, 2023.
Who are the main investors in OncoDNA?
Key investors in OncoDNA include Ackermans & van Haaren, Vesalius Biocapital Partners.
Will OncoDNA IPO soon?
No public IPO plans have been announced for OncoDNA.
How can I track OncoDNA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoDNA's secondary market activity and sign up for updates.